Document is current
Any future updates will be listed below
-
Authors
Prieur, Alexandre
Harper, Andrew
Khan, Momtafin
Vire, Bérengère
Joubert, Dominique
Payen, Léa
Kopciuk, Karen
- License Information
-
More Information
Article History
Received: 14 December 2022
Accepted: 10 March 2023
First Online: 4 April 2023
Declarations
:
: Ethics approval for this study (HREBA.CC-19–0318) was granted from the Health Research Ethics Board of Alberta-Cancer Committee. Informed consent was obtained from all subjects involved in the Breast to Bone (B2B) study. This research project was carried out in accordance with relevant guidelines and regulations in the Declaration of Helsinki.
: Not applicable.
: D.J. is the Senior Scientific Advisor of Biodena Care. A.P. is the Chief Scientific Officer of Biodena Care. B.V. is the Medical Science Liason at Biodena Care. The remaining authors declare no competing interests.
